Foster Dykema Cabot & Partners, LLC Abbott Laboratories Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.19 Trillion
- Q3 2024
A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 7,494 shares of ABT stock, worth $867,355. This represents 0.07% of its overall portfolio holdings.
Number of Shares
7,494
Previous 6,151
21.83%
Holding current value
$867,355
Previous $639 Million
33.68%
% of portfolio
0.07%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding ABT
# of Institutions
3,185Shares Held
1.35BCall Options Held
8.53MPut Options Held
7.24M-
Vanguard Group Inc Valley Forge, PA168MShares$19.4 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.61 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.61 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.17 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $203B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...